CompaniesNeuroBionics

NeuroBionics

active

Somerville, MA, United States

Founded 2023

About

Minimally invasive, implantable endovascular neuromodulation devices

Areas of Focus

Categories

Uncategorized Medical DeviceBoston & New England

Team (13)

Clinical Advisor, Neurology

Erik Mulchandani

Quality Systems & Regulatory Affairs

Erin Byrne Rousseau, PhD

Senior Biomedical Engineer

Engineering Technician

Ferdinand Hui, MD, FSNIS

Clinical Advisor, Endovascular Neurosurgery

Jeff Kramer, PhD

Business Advisor

View all 13 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

330

By Phase

PHASE2/PHASE3: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2013

2014

2015

2016

2017

2018

Today

Hover over trial bars to see details

Recent Trials

NCT02332005Lead Sponsor

12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study

PHASE2/PHASE3Completed

330 participants

Started: Nov 30, 2014 · Completed: Nov 30, 2017

Locations (1)

Headquarters

Somerville, MA, United States

Map

Loading map...